HIV progression and predictors of mortality in a community-based cohort of Zambian adults

Journal of the International Association of Physicians in AIDS Care

Volumn 7, Issue 1, 2008, Pages 17-26

  Kitchen, Maria ^a,c   Quigley, Maria A ^b   Mwinga, Alwyn M ^a   Fuchs, Dietmar ^c   Lisse, Ida M ^d   Porter, John D H ^b   McAdam, Keith P W J ^e   Godfrey Faussett, Peter ^b  

^a UNIVERSITY TEACHING HOSPITAL   (Zambia)

^b LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE   (United Kingdom)

^c INNSBRUCK MEDICAL UNIVERSITY   (Austria)

^d STATENS SERUM INSTITUT   (Denmark)

^e MAKERERE UNIVERSITY   (Uganda)

Author keywords

Africa; anemia; CD4 count; gender; HIV progression; mortality; neopterin

Indexed keywords

BIOLOGICAL MARKER; NEOPTERIN;

ADULT; AGE DISTRIBUTION; ANEMIA; ARTICLE; BLOOD; CD4 LYMPHOCYTE COUNT; COHORT ANALYSIS; DISEASE COURSE; FEMALE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNOLOGY; KAPLAN MEIER METHOD; MALE; MORTALITY; PROGNOSIS; SEX RATIO; ZAMBIA;

ADULT; AGE DISTRIBUTION; ANEMIA; BIOLOGICAL MARKERS; CD4 LYMPHOCYTE COUNT; COHORT STUDIES; DISEASE PROGRESSION; FEMALE; HIV INFECTIONS; HUMANS; KAPLAN-MEIER ESTIMATE; MALE; NEOPTERIN; PROGNOSIS; SEX DISTRIBUTION; ZAMBIA;

EID: 60649086784     PISSN: 15451097     EISSN: 15570886     Source Type: Journal    
DOI: 10.1177/1545109707303989     Document Type: Article

References (39)

1. Whittle H., Egboga A., Todd J., et al. Clinical and laboratory predictors of survival in Gambian patients with symptomatic HIV-1 or HIV-2 infection. AIDS. 1992 ; 6: 685-689.
2. N'gali B., Ryder RW, Kapita B., et al. Human deficiency virus infection among employees in an African hospital. N Engl J Med. 1988 ; 319: 1123-1127.
3. Colebunders R., Ryder R., Francis H., et al. Seroconversion rate, mortality and clinical manifestations associated with the receipt of a human immunodeficiency virus-infected blood transfusion in Kinshasa, Zaire. J Infect Dis. 1991 ; 164: 450-456.
4. Morgan D., Mahe C., Mayanja B., et al. HIV-1 infection in rural Africa: is there a difference in median time to AIDS and survival compared with that in industrialized countries? AIDS. 2002 ; 16: 597-603. (Pubitemid 34218855)
5. Collaborative group on AIDS Incubation and HIV Survival including the CASCADE EU Concerted Action. Time from HIV-1 seroconversion to AIDS and death before widespread use of highly-active antiretroviral therapy: a collaborative re-analysis. Lancet. 2000 ; 355: 1131-1137.
6. Hendriks JCM, Satten GA, van Ameijden EJC, et al. The incubation period to AIDS in injecting drug users estimated from prevalent cohort data accounting for death prior to an AIDS diagnosis. AIDS. 1998 ; 12: 1537-1544. (Pubitemid 28369655)
7. Koblin BA, van Benthem BH, Buchbinder SP, et al. Long term survival after infection with human immunodeficiency virus type 1 (HIV-1) among homosexual men in hepatitis B vaccine trial cohorts in Amsterdam, New York City, and San Francisco, 1978-1995. Am J Epidemiol. 1999 ; 150: 1026-1030. (Pubitemid 29531938)
8. Leroy V., Msellati P., Lepage P., et al. Four years of natural history of HIV-1 infection in African women: a prospective cohort study in Kigali (Rwanda), 1988-1993. J Aquir Immune Defic Syndr. 1995 ; 9: 415-421.
9. Senkoro KP, Boerma JT, Klokke AH, et al. HIV incidence and HIV-associated mortality in a cohort of factory workers and their spouses in Tanzania, 1991 through 1996. J Aquir Immune Defic Syndr. 2000 ; 23: 194-202. (Pubitemid 30316845)
10. Mekonnen Y., Geskus RB, Hendriks JCM, et al. Low CD4 T cell counts before HIV-1 seroconversion do not affect disease progression in Ethiopian factory workers. J Infect Dis. 2005 ; 192: 739-748. (Pubitemid 41193071)
11. Urassa M., Boerma JT, Isingo R., et al. The impact of HIV/AIDS on mortality and household mobility in rural Tanzania. AIDS. 2001 ; 15: 2017-2023. (Pubitemid 32980645)
12. Todd J., Balira R., Grosskurth H., et al. HIV-associated adult mortality in a rural Tanzanian population. AIDS. 1997 ; 11: 801-807. (Pubitemid 27186951)
13. Crampin AC, Floyd S., Glynn JR, et al. Long term follow-up of HIV-positive and HIV-negative individuals in rural Malawi. AIDS. 2002 ; 16: 1545-1550. (Pubitemid 34804220)
14. Nunn AJ, Mulder DW, Kamali A., et al. Mortality associated with HIV-1 infection over five years in a rural Ugandan population: cohort study. BMJ. 1997 ; 315: 767-771. (Pubitemid 27405942)
15. French N., Mujugira A., Nakiyingi J., et al. Immunologic and clinical stages in HIV-1-infected Ugandan adults are comparable and provide no evidence of rapid progression but poor survival with advanced disease. J Aquir Immune Defic Syndr. 1999 ; 22: 509-516. (Pubitemid 30027503)
16. Bwayo JJ, Nagelkerke NJD, Moses S., et al. Comparison of the declines in CD4 counts in HIV-1 seropositive female sex workers and women from the general population in Nairobi, Kenya. J Aquir Immune Defic Syndr. 1995 ; 10: 457-461.
17. Urassa W., Bakari M., Sandstrm E., et al. Rate of decline of absolute number and percentage of CD4 T lymphocytes among HIV-1 infected adults in Dar es Salaam, Tanzania. AIDS. 2004 ; 18: 433-438. (Pubitemid 38365870)
18. Schim van der Loeff MF, Jaffar S., Aveika AA, et al. Mortality of HIV-1, HIV-2 and HIV-1/HIV-2 dually infected patients in a clinic-based cohort in The Gambia. AIDS. 2002 ; 16: 1775-1783.
19. Katubulushi M., Zulu I., Yavwa F., Kelly P.: Slow decline in CD4 cell count in a cohort of HIV-infected adults living in Lusaka, Zambia. AIDS. 2004 ; 19: 102-103. (Pubitemid 40111028)
20. Mwinga A., Hosp M., Godfrey-Faussett P., et al. Twice weekly tuberculosis preventive therapy in HIV infection in Zambia. AIDS. 1998 ; 12: 2447-2457. (Pubitemid 28558603)
21. Quigley MA, Mwinga A., Hosp M., et al. Long term effect of preventive therapy for tuberculosis in a cohort of HIV-infected Zambian adults. AIDS. 2001 ; 15: 215-222. (Pubitemid 32142297)
22. Lisse IM, Whittle H., Aaby P., et al. Labelling of T cell subsets under field conditions in tropical countries: adaptation of the immuno-alkaline phosphatase staining method for blood smears. J Immunol Methods. 1990 ; 129: 49-53. (Pubitemid 20141317)
23. Lisse IM, Boettiger B., Christensen LB, et al. Evaluation of T cell subsets by an immunocytochemical method compared to flow cytometry in four countries. Scand J Immunol. 1997 ; 45: 637-644. (Pubitemid 27250232)
24. Hosp M., Lisse IM, Quigley M., et al. An evaluation of low-cost progression markers in HIV-1 seropositive Zambians. HIV Med. 2000 ; 1: 1-3.
25. Del Amo J., Malin AS, Poznak A., De Cock KM Does tuberculosis accelerate the progression of HIV disease? Evidence from basic science and epidemiology. AIDS. 1999 ; 13: 1151-1158. (Pubitemid 29361083)
26. Corbett EL, De Cock KM. The clinical significance of interactions between HIV and tuberculosis: more questions than answers. Int J Tuberc Lung Dis. 2001 ; 5: 205-207. (Pubitemid 32397595)
27. Day JH, Grant AD, Fielding KL, et al. Does tuberculosis increase HIV load? J Infect Dis. 2004 ; 190: 1677-1684. (Pubitemid 39411019)
28. Wilkinson D. Drugs for preventing tuberculosis in HIV-infected persons. Cochrane Database Syst Rev. 2002: CD000171.
29. Mocroft A., Johnson MA, Phillips AN Factors affecting survival in patients with the acquired immunodeficiency syndrome (review). AIDS. 1996 ; 10: 1057-1065. (Pubitemid 26283342)
30. Prins M., Robertson JR, Brettle RP, et al. Do gender differences in CD4 cell counts matter? AIDS. 1999 ; 13: 2361-2364.
31. Lemp GF, Payne SF, Neal D., et al. Survival trends for patients with AIDS. JAMA. 1990 ; 263: 402-406. (Pubitemid 20026014)
32. Mildvan D., Spritzler J., Grossberg SE, et al. Serum neopterin, an immune activation marker, independently predicts disease progression in advanced HIV infection. CID. 2005 ; 40: 853-858. (Pubitemid 40365506)
33. Hosp M., Quigley M., Mwinga AM, et al. Neopterin and other indicators of HIV progression in Zambian adults. Pteridines. 2000 ; 11: 37-42.
34. Fuchs D., Hausen A., Reibnegger G., et al. Immune activation and the anaemia associated with chronic inflammatory disorders. Eur J Haematol. 1991 ; 46: 65-70.
35. Mocroft A., Kirk O., Barton SE, et al. Anaemia is an independent predictive marker for clinical prognosis in HIV-infected patients from across Europe. AIDS. 1999 ; 13: 943-950. (Pubitemid 29240189)
36. O'Brien ME, Kupka R., Msamanga GI, et al. Anemia is an independent predictor of mortality and immunologic progression of disease among women with HIV in Tanzania. J Aquir Immune Defic Syndr 2005 ; 40: 219-225. (Pubitemid 41395722)
37. Phillips AN, Lee CA, Elford J., et al. More rapid progression to AIDS in older HIV-infected people: the role of CD4+ T-cell counts. J Aquir Immune Defic Syndr. 1991 ; 4: 970-975.
38. Lang W., Perkins H., Anderson RE, et al. Patterns of T-lymphocyte changes with human immunodeficiency virus infection: from seroconversion to the development of AIDS. J Aquir Immune Defic Syndr. 1989 ; 2: 63-69. (Pubitemid 19127077)
39. Nishanian P., Taylor JMG, Manna B., et al. Accelerated changes (inflection points) in levels of serum immune activation markers and CD4 and CD8 T cells prior to AIDS onset. J Aquir Immune Defic Syndr. 1998 ; 18: 162-170.